市场调查报告书
商品编码
1441344
全球大麻测试市场规模、份额、成长分析(按技术、测试、最终用户)- 2023-2030 年产业预测Global Cannabis Testing Market Size, Share, Growth Analysis, By Technology, By Test, By End User - Industry Forecast 2023-2030 |
2022年全球大麻测试市场规模为70亿美元,预计将从2023年的79亿美元成长到2031年的219亿美元,在预测期间(2024-2031年)复合CAGR为13.5%。
由于大麻萃取物用于治疗各种神经和精神疾病,以及大麻产量和盛行率的成长,全球大麻测试市场正在迅速扩张。在预测期内,这种成长趋势预计将导致大麻测试市场显着扩张。欧洲大脑委员会估计,全球约有 600 种神经系统异常现象,这使得精神疾病成为全球疾病和损伤的主要原因之一。忧郁症是全球最常见的精神疾病,影响超过 2.64 亿各年龄层的人,其中女性发病率更高。大麻测试对于评估大麻药物的安全性和有效性非常重要,从其日益普及的情况可以看出。此外,大麻研究实验室对软体服务的接受度和认可度不断提高。
Global Cannabis Testing Market size was valued at USD 7 billion in 2022 and is poised to grow from USD 7.9 billion in 2023 to USD 21.9 billion by 2031, growing at a CAGR of 13.5% during the forecast period (2024-2031).
The Global Cannabis Testing Market is experiencing rapid expansion owing to the use of cannabis extracts in the treatment of various neurological and mental conditions, in tandem with the growth in cannabis production and prevalence. Over the course of the forecast period, this increasing tendency is anticipated to create significant expansion in the cannabis testing market. The European Brain Council estimates that there are about 600 neurological abnormalities registered globally, making mental illnesses one of the main causes of illness and impairment worldwide. Depression is the most common mental illness worldwide, affecting over 264 million people of all ages, with a higher incidence in women. Cannabis testing is important for assessing the safety and effectiveness of cannabis-based medicines, as seen by its increasing prevalence. Furthermore, the growing acceptance and recognition of software services in cannabis research laboratories.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cannabis Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cannabis Testing Market Segmental Analysis
The global cannabis testing market is segmented into three segments i.e. by technology, test and region. Based on Technology the market is segmented as, chromatography, gas chromatography, spectroscopy, liquid chromatography, atomic spectroscopy, mass spectrometry and others. Based on end user the market is segmented as, laboratories, cannabis cultivators and growers, cannabis drug manufacturers and dispensaries, and other end users. Based on test the market is segmented as, potency testing, pesticide screening, residual solvent screening, heavy metal testing, terpene testing, mycotoxin testing, and others. Based on regions the market is segmented as, North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa.
Drivers of the Global Cannabis Testing Market
One of the major drivers of this market is the legalization of medical cannabis along with the rise in number of cannabis testing laboratories worldwide. With its ability to reduce symptoms and improve patients' quality of life, medical cannabis has emerged as a promising treatment option for a wide range of illnesses. Its noteworthy effects include reducing nausea from chemotherapy, promoting appetite in AIDS patients, and controlling spasms in the muscles of people with multiple sclerosis. These claims are backed by a wealth of evidence.
Restraints in the Global Cannabis Testing Market
The lack of standardized testing methodologies poses a significant obstacle to the growth of the cannabis testing sector. The absence of consistency in testing protocols creates a significant obstacle, particularly with respect to the accurate dosage of cannabis meant for therapeutic use. The reliability and consistency of cannabis-based pharmaceuticals are seriously compromised by the scattered nature of quality standards that are in place across different states.
Market Trends of the Global Cannabis Testing Market
Strong government support for the legalization of medical marijuana in these areas is what is fueling this expansion. Investors, significant business players, and governmental organizations are drawn to this supporting posture toward medical cannabis legalization as they look for possibilities to invest in expanding the infrastructure for cannabis testing.